Skip to main content

This translation is provided for general access and has no recorded medical-language review.

Editorial general information — not a clinical-review record

Published: Updated: Publisher: Dr. Murat Toktamışoğlu

Why do randomization, blinding and controls matter in exosome studies?

Hydration, redness and appearance can change with time, skincare and a co-procedure. Randomization balances groups, blinded assessment reduces expectation effects, and a suitable vehicle or procedure control tests whether a difference can be attributed to the EV component.

This translation has no recorded clinical or medical-language review.

Direct answer

  • A single-arm before-and-after study cannot separate natural change and expectation effects.
  • A split-face design reduces personal variation but still faces crossover and photographic-unblinding problems.
  • The control should match the carrier and any laser or microneedling procedure as closely as possible.

What does randomization balance?

Age, sun exposure, baseline wrinkles, skincare and healing capacity affect outcomes. Random allocation of participants or facial sides aims to balance known and unknown factors on average. If the next assignment can be predicted, selection bias returns. Randomization cannot guarantee perfect balance in a small study, so baseline characteristics and the analysis plan still require reporting.

How can blinding fail?

If an EV product has a different smell, consistency, colour or reaction, the participant and operator may infer the side. A reviewer may recognize treatment marks, lighting or side labels in photographs. Blinding should describe the masking method and whether guesses were tested. Participant satisfaction is valuable, but it is not the same outcome as a blinded instrument measurement or independent clinical score.

Without the right control, component effect is uncertain

Microneedling, laser or a moisturizing carrier can produce an outcome on its own. If one side receives procedure plus EV and the other nothing, the active contributor is unclear. A suitable control attempts to match vehicle, frequency and co-procedure. A 2026 systematic review rated certainty for facial EV evidence low to very low and most effectiveness outcomes at moderate-to-critical risk of bias, so one positive small study is not a product-specific promise.

Scope of this article

This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.

Sources and evidence limits

These links are editorial starting points used to examine the article's boundaries.

  1. Microneedling for Facial Rejuvenation: A Systematic Review

    Foppiani JA et al. · 2025

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  2. Evaluating the Effectiveness and Safety of Radiofrequency for Face and Neck Rejuvenation: A Systematic Review

    Austin GK, Struble SL, Quatela VC · 2022

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  3. Energy-Based Devices for the Treatment of Facial Skin Conditions in Skin of Color

    Sanyal RD, Fabi SG · 2024

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  4. Potential Risks with Certain Uses of Radiofrequency (RF) Microneedling – FDA Safety Communication

    U.S. Food and Drug Administration (FDA) · 2025

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  5. A Systematic Review and Meta-Analysis of Efficacy, Safety, and Satisfaction Rates of Laser Combination Treatments vs Laser Monotherapy in Skin Rejuvenation Resurfacing

    Pour Mohammad A et al. · 2023

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  6. Outcomes and Adverse Effects of Ablative vs Nonablative Lasers for Skin Resurfacing: A Systematic Review of 1093 Patients

    Mirza HN, Mirza FN, Khatri KA · 2021

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  7. Medical Lasers

    U.S. Food and Drug Administration (FDA) · 2023

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  8. Effectiveness and Safety of Extracellular Vesicle-Based Therapies for Nonsurgical Facial Rejuvenation: A Systematic Review

    K. Gaebe et al. · 2026

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  9. A Systematic Review and Meta-Analysis of Clinical Trials Assessing Safety and Efficacy of Human Extracellular Vesicle-Based Therapy

    Systematic review authors · 2024

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  10. Minimal Information for Studies of Extracellular Vesicles (MISEV2023)

    International Society for Extracellular Vesicles contributors · 2024

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review